To: Sino Haijing Holdings Limited (the “Company”)
I/We would like to receive the Corporate Communications(Note 3)
of the Company in the manner as indicated below:
(Please tick ONLY ONE box
To receive Corporate Communications via the Company’s website
(the “Company Website”) and
to receive the notification of publication of Corporate Communications
(the “Notification”) through my/our email address(Note 4)
To receive the printed English version(Note 5)
of the Corporate Communications.
To receive the printed Chinese version(Note 5)
of the Corporate Communications.
To receive both the printed English and Chinese versions(Note 5)
of the Corporate
Please complete your choice of the means of receipt and/or language(s) of Corporate Communications and all your details clearly.
If you do not complete this Reply Form and return it to the Branch Registrar of the Company at the address indicated
above by 10 March 2009, you will be DEEMED to have agreed to receive Corporate Communications via the Company
Website and a printed copy of the Notification will be sent to you by post when such Corporate Communication(s) is/are
posted on the Company Website.
Corporate Communications refer to any documents issued or to be issued by the Company for information or action of shareholders of the Company, including but not limited to annual report, half-year report, quarterly report, notice of meeting, listing document, circular and proxy form.
Please provide your email address if you wish to receive the Notification via email. If no email address is provided, a printed copy of the Notification will be sent to you by post when Corporate Communications(s) is/are posted on the Company Website.
The Company will send the selected language version(s) of the Corporate Communication(s) to you unless and until you notify the Company that you wish to receive such Corporate Communication(s) in the other (or both) language(s) or to change your choice of the means of receipt of Corporate Communications.
If your shares are held in joint names, the shareholder whose name stands first on the register of members of the Company in respect of the joint holdings should sign this Reply Form in order for it to be valid.
You are entitled at any time to change your choice of the means of receipt (either in printed form or via the Company Website) and/or language(s) (either English only or Chinese only or both languages) of Corporate Communications by notice in writing to the Branch Registrar of the Company, Tricor Tengis Limited at 26/F., Tesbury Centre, 28 Queen’s Road East, Wanchai, Hong Kong or by sending an email to the Branch Registrar of the Company at firstname.lastname@example.org.
This Reply Form with no box ticked, with more than one box ticked, or otherwise incorrectly completed will be voided at the discretion of the Company.
Vergütungsvereinbarung für ärztliche Leistungen zur Diagnostik und ambulanten Eradikationstherapie von Trägern mit dem Methicillin-resistenten Staphylcoccus aureus (MRSA) in der vertragsärztlichen Versorgung gemäß § 87 Abs. 2a SGB V mit Wirkung zum 01.04.2012 bis zum 31.03.2014 Allgemeine Fragen zu MRSA Was bedeutet "Eradikationstherapie"? Vollständige Eliminierung e
ESTRADIOL BOVINE ESTRADIOL ELISA TEST KIT PRODUCT PROFILE AND INSTRUCTIONS INTENDED USE The Microwell Estradiol ELISA TEST is an enzyme immunoassay system for quantitative determination of 17 beta Estradiol levels in bovine and related species serum. The test is intended for professional use as research tool in monitoring of conditions related to serum/plasma levels of Estradiol.